Return
Company Page
En Carta Diagnostics
En Carta Diagnostics is a Paris-based DeepTech company developing a new generation of at-home molecular diagnostics that combine the precision of laboratory PCR with the simplicity of a rapid test. Built on aptamer-based synthetic biology technology with over a decade of research behind it, its proprietary platform delivers results in 30 minutes without laboratory infrastructure. The company's flagship product targets early Lyme disease detection, with an expanding pipeline into STI screening for chlamydia and gonorrhoea across Europe and the US.
Company Founded in 2022
Healthtech & Biotech